AVHC's Portable Hyperbaric Chamber Saves Limbs of Diabetic Patients.

Business Editors/Health/Medical Writers

OMAHA, Neb.--(BUSINESS WIRE)--July 16, 2003

Advanced Healthcare Technologies, Inc. (OTCBB:AVHC) today announced that in two recent cases AVHC's Topical Hyperbaric Oxygen Extremity Chambers were utilized to treat patients suffering from diabetes who had non-healing infected wounds on their extremities. Both patients were facing the threat of below the knee amputations.

Dr. Frank Rossi, Medical Director of the St. Francis Hospital Wound Care Center in New Jersey and wound care expert, was recently called to consult on a diabetic patient with renal failure who had extensive gangrene on four toes on the left foot. The vascular surgeon had pronounced him unable to undergo bypass surgery and in need of a below the knee amputation. Dr. Rossi debrided (clean and remove dead tissue) the wound and utilized the AVHC THBO chamber in an attempt to salvage the limb. Over the next 90 days of treatment, the infection was eliminated, the wound is almost healed and the patient is no longer at risk of an amputation, thanks to the Chamber and Dr. Rossi.

The second patient, treated at Fairchild Medical Center in Yreka, Calif., had a post surgical infection after having several toes amputated and a chronic foot ulcer. His condition was brought to the attention of the facilities Rehab Manager, Marcus Iggoglio, who had experience in healing difficult wounds utilizing the Topical Hyperbaric Oxygen Chamber, and recommended the chamber as a last possibility, as the wound was severely infected and amputation was under consideration. Following the first treatment, the patient reported almost complete relief of the pain associated with the surgical procedure. Within two weeks significant healing of the incision area and ulcer area was noted. Over a sixty-day period the incision and the ulcerated area were almost completely healed.

There are more than 100 million people in the world suffering from diabetes. More than 16 million live in the United States. Approximately 15% -- 2.4 million -- diabetics will develop foot ulcers during their lifetime. About 500,000 of these diabetic ulcers will become infected and lead to lower extremity amputations. We believe that THBO, when used as one of the modalities, can reduce the number of amputations and/or lives lost.

Advanced Healthcare Technologies (OTCBB:AVHC) is a company that engages in the development and incubation of companies with products and services in the healthcare industry.

For further information, visit the Advanced Healthcare Technologies, Inc. website at www.advancedhealthcaretechnologies.com (currently being updated) and visit the Advanced Hyperbaric Technologies website at www.advanced-hyperbaric.com .

Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.